Federal contractors / THE JOHNS HOPKINS UNIVERSITY

Federal contract award

75N93019F00131

75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #002; POP 9/5/19-5/4/21

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAJ52 — LIFE SCIENCES - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT
Parent award / vehicle75N93019D00031
Set-asideNot reported
Pricing typeCOST NO FEE
Obligations$5.8M
Current contract value$5.8M
Potential contract value / ceiling$5.8M
Start dateSep 5, 2019
Current end dateNov 30, 2024
Potential end dateNov 30, 2024
Latest award activityNov 18, 2024
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Nov 18, 2024P00005$54.9KOPERATIONS OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID
Aug 26, 2024P00004$0OPERATIONS OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID
Aug 29, 2023P00003$1.3MOPERATIONS OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID
Apr 20, 2022P00002$2.0MOPERATIONS OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID
May 4, 2021P00001$0OPERATIONS OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID
Sep 3, 20190$2.4M75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #002; POP 9/5/19-5/4/21

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.